Your browser doesn't support javascript.
loading
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study.
Lus, G; Signoriello, E; Maniscalco, G T; Bonavita, S; Signoriello, S; Gallo, C.
Afiliação
  • Lus G; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
  • Signoriello E; Multiple Sclerosis Center, II Division of Neurology, Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy.
  • Maniscalco GT; Multiple Sclerosis Regional Center, A. Cardarelli, Naples, Italy.
  • Bonavita S; Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Naples, Italy.
  • Signoriello S; Medical Statistics Unit, Department of Mental Health and Preventive Medicine, Second University of Napoli, Napoli, Italy.
  • Gallo C; Medical Statistics Unit, Department of Mental Health and Preventive Medicine, Second University of Napoli, Napoli, Italy.
Eur J Neurol ; 23(3): 489-93, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26212486

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Avaliação de Resultados em Cuidados de Saúde / Esclerose Múltipla Recidivante-Remitente / Acetato de Glatiramer / Interferon beta-1a / Interferon beta-1b Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Avaliação de Resultados em Cuidados de Saúde / Esclerose Múltipla Recidivante-Remitente / Acetato de Glatiramer / Interferon beta-1a / Interferon beta-1b Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article